tiprankstipranks
pc:siftb

Sift Biosciences

Sift Biosciences is developing a peptide-based immunotherapy platform designed to harness pre-existing immune memory. The company aims to activate memory T cells to generate more consistent immune engagement, with applications across oncology and autoimmune diseases and an initial focus on immunologically cold solid tumors such as microsatellite-stable colorectal and ovarian cancers.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundPre-Seed
Latest Funding RoundPre-Seed
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Feb 18, 2026
Pre-Seed
$3.70M

Investors

Investor Name
Funding Round

Related News and Analysis